All Stories

  1. North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
  2. Two-year analysis of changes in the optic nerve and retina following anti-VEGF treatments in diabetic macular edema patients
  3. Safety of anti-VEGF treatments in a diabetic rat model and retinal cell culture
  4. Washout Duration of Prostaglandin Analogues: A Systematic Review and Meta-analysis
  5. The value of corneoscleral rim cultures in keratoplasty: a systematic review and cost-effectiveness analysis
  6. Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss
  7. New technique to maximize utility of ocular surface impressions
  8. When Is Evidence Enough Evidence? A Systematic Review and Meta-Analysis of the Trabectome as a Solo Procedure in Patients with Primary Open-Angle Glaucoma
  9. Aqueous misdirection syndrome: an interesting case presentation
  10. An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan® RC Early Analysis Review (CLEAR) trial
  11. An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial
  12. Efficacy of various antioxidants in the protection of the retinal pigment epithelium from oxidative stress
  13. Needs assessment of ophthalmology education for primary care physicians in training: comparison with the International Council of Ophthalmology recommendations
  14. Bacterial conjunctivitis
  15. Tolerability and effectiveness of preservative-free dorzolamide–timolol (preservative-free Cosopt®) in patients with open-angle glaucoma or ocular hypertension